John DeSimone - 17 Mar 2024 Form 3 Insider Report for HERBALIFE LTD. (HLF)

Role
Chief Financial Officer
Signature
Alaaeddine Sahibi, as Attorney-In-Fact for John DeSimone
Issuer symbol
HLF
Transactions as of
17 Mar 2024
Transactions value $
$0
Form type
3
Filing time
27 Mar 2024, 19:15:16 UTC
Previous filing
11 May 2022
Next filing
27 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding HLF Common Stock 281,544 17 Mar 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding HLF Stock Appreciation Rights 17 Mar 2024 Common Stock 116,560 $31.26 Direct F2
holding HLF Stock Appreciation Rights 17 Mar 2024 Common Stock 122,528 $28.6 Direct F3
holding HLF Stock Appreciation Rights 17 Mar 2024 Common Stock 216,847 $20.17 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Balance includes 75,154 unvested restricted stock units ("RSUs") previously granted to the Reporting Person, of which: 9,214 will vest on February 25, 2025, 32,969 will vest on February 16, 2025, and 32,971 will vest on February 16, 2026. All RSU vestings are subject to continued service through each applicable date.
F2 These stock appreciation rights were fully vested as of May 9, 2019.
F3 These stock appreciation rights were fully vested as of February 27, 2020.
F4 On February 16, 2023, the reporting person was granted 216,847 stock appreciation rights of which 1/3 has vested, and 1/3 will vest on February 16, 2025, and February 16, 2026.